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High tumor burden is associated with increased
levels of circulating inflammatory cytokines that in-
fluence the pathophysiology of the tumor and its
environment. The cellular and molecular events
mediating the organismal response to a growing tu-
mor are poorly understood. Here, we report a bidirec-
tional crosstalk between epithelial tumors and the fat
body—a peripheral immune tissue—in Drosophila.
Tumors trigger a systemic immune response through
activation of Eiger/TNF signaling, which leads to Toll
pathway upregulation in adipocytes. Reciprocally,
Toll elicits a non-tissue-autonomous program in adi-
pocytes, which drives tumor cell death. Hemocytes
play a critical role in this system by producing the
ligands Spa¨tzle and Eiger, which are required for
Toll activation in the fat body and tumor cell death.
Altogether, our results provide a paradigm for a
long-range tumor suppression function of adipo-
cytes in Drosophila, which may represent an evolu-
tionarily conserved mechanism in the organismal
response to solid tumors.
INTRODUCTION
Tumorigenesis is a very dynamic event that results in interactions
between different cell types and the production of proinflamma-
tory cytokines. In advanced cancers, which are characterized by
a high tumor burden, transformed epithelial cells release chemo-
kines and cytokines to recruit immune cells to the tumorigenic
lesion. Currently accepted as a hallmark of cancer (Hanahan
and Weinberg, 2011), tumor-related inflammation is a complex
and not well-understood process. It has been suggested that a
dynamic interaction between tumors and the immune system
is essential for tumor survival, growth, and metastasis (Mar-
uyama et al., 2011). However, studying the role of tumor-related
inflammation in advanced cancers in vivo is complicated by the
genetic redundancy of inflammatory cytokines and the ethicallimitations of inflicting high tumor burden on conventional labora-
tory animals.
Studies using the fruit fly Drosophila melanogaster provided
founding evidence for the existence of tumor suppressor genes,
with the discovery of the lethal (2) giant larvae (l(2)gl) mutant in the
1920s (Stern and Bridges, 1926). The scribble (scrib) group of tu-
mor suppressors, which includes the l(2)gl, discs large (dlg), and
scrib genes, has been extensively characterized for its role in the
establishment of apical basal polarity in epithelial cells (Bilder,
2004). Homozygous loss-of-function mutations of any of these
genes are sufficient to disrupt epithelial architecture and lead
to neoplastic transformation of mitotic tissues. Many studies
have focused on tissue autonomous roles of the scrib group in
tumorigenesis (Bilder et al., 2000; Bilder and Perrimon, 2000;
Brumby and Richardson, 2003; Doggett et al., 2011; Dow
et al., 2003; Froldi et al., 2008; Humbert et al., 2008; Wu et al.,
2010). However, little is known about the effects that a growing
tumor has on the physiology of the peripheral tissues. Previous
work by colleagues and us indicates that hemocytes are re-
cruited to neoplastic tumors, increase in number, and express
Eiger/tumor necrosis factor (TNF)-a (Cordero et al., 2010;
Pastor-Pareja et al., 2008). This suggested the existence of an
interaction between tumors and the immune system. Moreover,
it has been recently shown that tumors (like wounds) intersect
the Ecdysone system to delay metamorphosis (Colombani
et al., 2012; Cordero et al., 2010; Garelli et al., 2012). Recipro-
cally, the physiology of the host can influence tumors, because
dietary sugar can affect tumor progression via Insulin signaling
(Hirabayashi et al., 2013). Therefore, a complex crosstalk be-
tween growing tumors and the physiology of the animal is
evident. Nevertheless, which are the different components of
this systemic response and how they are connected remain
unclear.
In this study, we systematically examined the response to
tumor development in several tissues in Drosophila: the tumor
itself, the hemocytes, and the fat body. We report a bidirectional
communication between imaginal disc tumors and the fat body,
which is integrated by the hemocytes. In the presence of tumors,
the ligand Spa¨tzle —produced by hemocytes— activates Toll/
NF-kB signaling in the fat body. This activation within the fat
body is, in turn, required to induce tumor cell death throughCell Reports 6, 855–867, March 13, 2014 ª2014 The Authors 855
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Figure 1. Tumor Cell Death Depends on Hemocyte-Derived Eiger
(A–F) Immunofluorescence of normal wing discs (A) or imaginal disc tumors (B–F) from dlg40.2; hml-gal4 larvae expressing GFP (B), grim (C), RasV12 (D), an RNAi
transgene for eiger (egr-IR, E), and egr (F), stained for F-actin (green) and anticleaved caspase 3 (CC3, red, gray in A0–F0; arrows point to regions of CC3 staining).
(G and H) Quantifications of tumor volume (see Experimental Procedures; G, one-way ANOVA with Bonferroni post test correction, ***p < 0.001) and percentage
volume of tumor with apoptotic cells (H, one-way ANOVA with Bonferroni post test correction, *p < 0.05 and **p < 0.005). Error bars represent SEM in these and
subsequent figure panels.
See also Figures S1 and S2A–S2G.hemocyte-derived Eiger. Altogether, our results define a cellular
and molecular network mediating the systemic response to
tumors and uncover a tumor suppressor role of the fat body
through the activation of Toll signaling.
RESULTS
Hemocytes Directly Influence Tumor Size by Triggering
Apoptotic Cell Death
Current evidence in Drosophila cancer models indicates that
plasmatocytes, the phagocytic subtype of hemocytes (1) are re-
cruited to tumors, (2) increase in number, and (3) express the
Drosophila TNF-a ortholog (Cordero et al., 2010; Pastor-Pareja
et al., 2008). To gain further understanding into the role of
hemocytes, we introduced the hemocyte-specific driver hemo-
lectin-Gal4 (hml-Gal4) (Goto et al., 2001) into a dlg40.2 mutant
background (hereafter referred to as dlg40.2; hml > GFP) and
confirmed that dlg mutant larvae also displayed elevated856 Cell Reports 6, 855–867, March 13, 2014 ª2014 The Authorsnumbers of circulating hemocytes (Figure S1A; see Experimental
Procedures).
We tested whether, as in the case of scrib mutants (Pastor-
Pareja et al., 2008), there was a functional effect of hemocyte
number on dlg tumors. Increasing the number of hemocytes by
overexpressing RasV12 with hml-gal4 resulted in smaller dlg
imaginal disc tumors (dlg40.2; hml > RasV12), whereas reducing
hemocyte number by expressing the proapoptotic protein Grim
(dlg40.2; hml > grim) rendered larger tumors (Figures 1A–1D,
S1B, and S1C).
Remarkably, manipulations of hemocyte number directly
affected the levels of apoptotic cell death within tumors (Figures
1A–1D and S1D). Increased numbers of hemocytes in an other-
wise wild-type background (hml > RasV12) did not affect growth,
patterning, or the basal apoptotic rate observed in normal wing
imaginal discs (Figures S2B and S2F). Together, the results indi-
cate that hemocytes restrict tumor burden by inducing apoptotic
cell death.
Tumor Cell Death Requires Hemocyte-Derived Eiger
We have previously demonstrated that Eiger (Egr) produced by
the hemocytes is essential to trigger Egr signaling within tumor
cells (Cordero et al., 2010). We next tested whether Egr expres-
sion in hemocytes was important for triggering tumor cell death.
We specifically overexpressed or knocked down egr by RNAi in
hemocytes of dlgmutants (dlg40.2; hml > egr or dlg40.2; hml > egr-
IR, respectively). Tumors dissected from dlg40.2; hml > egr larvae
were significantly smaller and displayed increased cell death
relative to control ones (dlg40.2; hml > GFP). Critically, dlg40.2;
hml > egr-IR tumors were bigger than controls and displayed
no signs of apoptosis (Figures 1E–1H). No defects were detect-
able when egr was overexpressed in the hemocytes of tumor-
free control animals (Figures S2A and S2E), indicating that egr
expression in hemocytes does not induce cell death in normal
epithelial cells. Moreover, when we combined RasV12 and egr-
IR expression in hemocytes (dlg40.2; hml > RasV12; egr-IR) egr
knockdown was sufficient to compromise the tumor suppressor
activity of hemocytes even in the presence of increased hemo-
cyte number (Figures 2A–2D). Altogether, our results demon-
strate that hemocyte-derived Egr exerts its tumor suppressive
role through the induction of tumor cell death by apoptosis.
Immunolabeling of the Egr protein is observed as intracellular
puncta within scrib and dlg tumor cells and at the plasma mem-
brane of tumor-associated hemocytes (Cordero et al., 2010;
Igaki et al., 2009). To further investigate the requirement of
hemocyte-derived Egr for tumor cell death, we imaged a
Venus-tagged form of Egr expressed in hemocytes of tumor-
free animals or dlg40.2 mutants (he > egrvenus or dlg40.2; he >
egrvenus). Hemocytes expressing egrvenuswere found associated
to wild-type imaginal discs, as well as imaginal disc tumors (Fig-
ures 2E–2H). However, we observed Venus-positive puncta
outside hemocytes exclusively in tumor cells (Figures 2F and
2H; arrows). Across the imaginal disc tumors, the regions
of Venus-positive puncta partly correlated with regions of
apoptotic cell death, and numerous tumor cells displayed both
Venus puncta and cleaved caspase staining (Figures 2H and
S2H). This phenomenon was never observed in wild-type
epithelia where Egrvenus was confined to the associated hemo-
cytes (Figures 2E and 2G). Altogether, these results further indi-
cate that hemocyte-derived Egr induces tumor apoptosis and
restricts tumor growth via a non-cell-autonomous mechanism.
Eiger Is Required for Hemocyte Proliferation through
Production of Pvf
Wenext looked into themechanisms involved in the regulation of
hemocyte proliferation in tumor-bearing larvae, which we found
essential to trigger tumor cell death (e.g.; Figure 1). We observed
that loss of egr was sufficient to decrease the number of circu-
lating hemocytes in scrib tumor-bearing larvae (Figure 3A).
Drosophila Pvfs are orthologs of vertebrate VEGF/PDGF and
have been shown to drive hemocyte migration and proliferation
in different contexts (Munier et al., 2002; Parisi and Vidal, 2011;
Wood et al., 2006). Quantitative RT-PCR (qRT-PCR) on scrib1
imaginal discs demonstrated an increase in the expression of
pvf1 compared to wild type discs, which was dependent on
egr (Figure 3B). Consistently, RNAi knockdown of the Pvf Recep-
tor Pvr in hemocytes of dlgmutants using hml-gal4 or hemesee-gal4 (dlg40.2; hml > Pvr-IR or dlg40.2; he > Pvr-IR) reduced the
number of circulating hemocytes in dlg larvae (Figures 3C and
S3A). We next tested the functional relevance of Pvf1/Pvr
signaling from hemocytes in tumor development. We found a
significant increase in the size of dlg40.2; hml > Pvr-IR tumors
compared to controls (Figure 3D–3F). Consistent with our previ-
ous results, the increase in tumor size was correlated with
reduced levels of cell death in dlg40.2; hml > Pvr-IR tumors (Fig-
ures 3D, 3E, and 3G).
Taken together, these results indicate that Eiger signaling
within the epithelial tumor impacts the host systemically through
upregulation of Pvf1, which signals in hemocytes through its re-
ceptor Pvr to drive hemocyte proliferation.
Tumor-Bearing Larvae Display Toll Activation in the
Fat Body
Given the systemic effects of tumors on hemocyte number, we
hypothesized that the fat body, which also plays a key role in
Drosophila innate immunity (Hoffmann, 1995), could be an active
component of the organismal response to tumors. We therefore
used reporter lines and qRT-PCR to screen for activation of path-
ways previously implicated in immunity such as the Immune
Deficient/Relish (IMD/Rel), Insulin Receptor (InR/FoxO), Egr/
JNK, and Toll/NF-kB pathways within adipocytes. We further
tested whether these candidate pathways were activated in a
non-tissue-autonomous manner (i.e.; activated in adipocytes
from both zygotic mutant larvae as well as in larvae containing
eye imaginal disc tumors but otherwise wild-type; see the Exper-
imental Procedures). Using these criteria, we failed to detect any
significant change in the fat body activity of IMD/Rel, InR/FoxO,
and Egr/JNK pathways (Figures S4A–S4I). However, the expres-
sion of a Toll/NFkB pathway reporter, drosomycin (drs) (Ferran-
don et al., 1998), was dramatically upregulated in the fat body
of most zygotic scrib1 and l(2)gl mutant larvae (Figures 4A–4F)
as well as in larvae-bearing RasV12; scrib1 eye imaginal disc tu-
mors (Figure 4J). Similarly, we observed fat body upregulation
of defensin, an independent Toll target (Figure S4K).
drs-GFP was still upregulated in the fat body of scrib1 mutant
larvae raised in germ-free-like conditions (Figures 4G–4I; see
Experimental Procedures), suggesting that Toll pathway upregu-
lation in the fat body was indeed due to the presence of tumors
and not secondary to pathogenic infection. Finally, we failed to
detect Toll signaling activation in the fat body of developmentally
arrested ecd1mutants (Figure 4J), indicating the effect was not a
result of developmental delay.
Altogether, these results suggest a direct influence of
developing Drosophila epithelial tumors on the adipose tis-
sue, which is manifested by the activation of Toll signaling in
the latter.
Hemocytes Are Essential Mediators of the Crosstalk
between Tumors and the Fat Body
The secreted ligand Spa¨tzle (Spz) binds to the Toll receptor and
activates downstream signaling during the immune response to
infection (Shia et al., 2009) (Lemaitre and Hoffmann, 2007).
We next tested a potential role of hemocyte-derived Spz in
the activation of Toll in the fat body of tumor-bearing larvae.
Targeted knockdown of Spz within hemocytes by RNAiCell Reports 6, 855–867, March 13, 2014 ª2014 The Authors 857
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Figure 2. Hemocyte-Derived Eiger Is Incorporated into Tumor Cells
(A and B) Immunofluorescence of tumors from dlg40.2; hml-gal4 larvae expressing RasV12 alone (A) or in combination with egrRNAi (RasV12; egr-IR, B), which were
stained for F-actin (green) and CC3 (red and gray in A0 and B0 ).
(C and D) Quantification of tumor volume (C, t test ****p < 0.0001) and percentage volume of tumor with apoptotic cells (D, t test ****p < 0.0001).
(E and F) Control wing disc (E) and dlg40.2 tumor (F) from larvae expressing UAS-egrvenus under the control of he-gal4. Arrowheads point to tissue associated
hemocytes; arrows point to Egr-Venus puncta located within epithelial tumor cells. (E0)–(F00) show a high-magnification view from the boxed areas in (E) and (F).
(G and H) Control wing discs (G) and wing disc tumors from dlg40.2 larvae (H) expressing UAS-egrvenus under the control of cg-gal4 and stained with anticleaved
caspase 3. Arrowheads and arrows are as in (F0). Note that the regions of Egrvenus positive puncta were often seen within regions of caspase activation (arrows)
and pycnotic nuclei (not shown). (G0)–(H0) show high-magnification view from the boxed areas in (G) and (H).
See also Figure S2H.
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Figure 3. Eiger Drives Hemocyte Proliferation via Pvf1 to Restrict Tumor Growth
(A) Quantification of hemocyte density from the indicated genotypes (t test **p = 0.0013).
(B) qRT-PCR of pvf1 in WT wing discs and wing disc tumors dissected from the genotypes indicated.
(C) Hemocyte density was quantified in the indicated genotypes (t test **p = 0.0011). Note the decrease in hemocyte number in animals with hemocyte-specific
knockdown of pvr achieved with hml-gal4.
(D and E) Immunofluorescence of tumors from dlg40.2; hml-gal4 larvae expressing GFP or pvr-IR as indicated and stained for F-actin and CC3.
(F and G) Quantifications of tumor volume (F, t test ***p = 0.0006) and percentage volume of tumor with apoptotic cells (G, t test ***p = 0.0002).
See also Figure S3.(dlg40.2; hml>spz-IR) resulted in reduced Toll activation in the fat
body of dlg mutants, as indicated by qRT-PCRs for drs mRNA
(Figure 4K). Consistent with the production of the Toll ligand
Spz by hemocytes, expanding the population of hemocytes byoverexpressing RasV12 enhanced Toll reporter activation in the
fat body (dlg40.2; hml > RasV12; Figure 4K).
Together these results indicate that tumor-driven activation of
Toll signaling in the fat body is mediated by hemocyte secretionCell Reports 6, 855–867, March 13, 2014 ª2014 The Authors 859
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Figure 4. Tumor-Bearing Larvae Display Toll Pathway Activation in Their Fat Body
(A and B) drosomycin-GFP (drs-GFP, green) fluorescent signal (counterstained with DAPI for nuclei in blue) from dissected fat bodies (A and B) or wing
discs (A0 and B0) from wild-type controls (WT) and mutants for lethal (2) giant larvae (l(2)gl4/Defnet62). Note that, in lgl4 mutants, the drs-GFP reporter was
activated in the fat body in a patchy manner (arrow in B points to an adipocyte with relatively lower levels of drs-GFP expression) but not in the imaginal disc
tumors (B0).
(legend continued on next page)
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of Spz and points to hemocytes as a link for long-range sensing
of tumor burden by the immune system.
Tumor-Intrinsic Egr Activates Toll in the Fat Body
Having established that Egr signaling within the tumors is
required for hemocyte proliferation (Figure 3A) and that hemo-
cyte-derived Spz is necessary for Toll activation in the fat body
(Figure 4K), we next tested whether there was a functional
connection between Egr and Toll activation. Remarkably, the
upregulation of drs in the fat body of scrib1 larvae was prevented
upon systemic loss of egr (egr3; scrib1; Figures 5A–5C).
We next tested whether tumor- and/or immune tissue-derived
Egrwas required for Toll activation in the fat body.Overexpression
orRNAi knockdownof Egr in both hemocytes and the fat body us-
ing cg-gal4 (dlg40.2; cg > egr or dlg40.2; cg > egr-IR) did notmodify
drs mRNA levels (Figure 5D). Moreover, reducing or enhancing
expression of Egr specifically in hemocytes (dlg40.2; hml > egr-IR
or dlg40.2; hml > egr) did not significantly affect drs mRNA in the
fat body of dlg mutants (Figure 5E). These results suggest that a
source of Egr distinct from the hemocytes and the fat body itself
is responsible for thisEgr-dependent Toll activation in adipocytes.
To test the role of tumor-derived Egr in this process, we cosi-
lenced dlg and egr in the wing pouch using scalloped (sd)-gal4
driver. Consistent with our previous observations,dlg knockdown
in the sddomainwassufficient to triggeractivationof Toll signaling
in the fat body (drs-GFP/sd > dlg-IR; Figures 5F and 5F0).
Importantly, this effect was never observed in fat bodies from
drs-GFP/sd > dlg-IR; egr-IR larvae, even though the wing disc
pouches displayed increased overgrowth (Figures 5G and 5G0).
Altogether, these results indicate that egr expression within
epithelial tumors is required to activate Toll in the fat body.
Toll Signaling Restrains Tumor Growth in a Non-Tissue-
Autonomous Manner
We next addressed the functional relevance of Toll signaling
activation in the fat body of dlg larvae. First, we noted that Spz
silencing in hemocytes (dlg40.2; hml > spz-IR or dlg40.2; he >
spz-IR) resulted in increased tumor size and decreased tumor
cell death (Figures 6A–6D and S5A–S5D). We then modulated
Toll signaling in the fat body using the pumpless-Gal4 (ppl-
Gal4) driver (Zinke et al., 1999). Tumors from larvaewith impaired
Toll activation in the fat body achieved through RNAi for the
Toll adaptor protein Myd88 (dlg40.2; ppl > Myd88-IR) were signif-
icantly bigger and displayed reduced cell death when compared
to controls tumors (Figures 6G, 6I, and 6J). These results were
confirmed by silencing Myd88 with two independent fat body
drivers (cg-gal4 and lsp2-gal4) (Figures S5F–S5K). Conversely,(C–F) Whole larva micrographs showing drs-GFP in WT (C), l(2)gl4/Def (E and F), a
signal. The larva in (E) was 9–10 days old and in (D) 11–12 days old.
(G) Demonstration of germ-free-like conditions using antibiotics (see Experimenta
streptomycin (P/S) containing diet (right side of plate) and homogenized and spr
(H and I) drs-GFP signal from animals raised in P/S treated diet from the indicate
when raised in germ-free-like conditions.
(J and K) qRT-PCR for drsmRNA from dissected fat bodies from the indicated gen
old. Note that drswas upregulated in scrib1mutant larvae as well as in larvae carry
mutant larvae who arrest at the larval stage as tumor-bearing larvae but are free o
(spz) in the hemocytes of dlg mutant larvae upregulated and downregulated drs
See also Figure S4.enhanced Toll activation in the fat body achieved by overex-
pression of wild-type Toll receptor (dlg40.2; ppl > Toll) resulted
in decreased tumor volume and increased tumor cell death (Fig-
ures 6H–6J). A similar overexpression of Toll in tumor-free ani-
mals did not cause ectopic cell death or patterning defects in
normal discs (Figures S2C and S2G). Finally, inhibiting Toll spe-
cifically within hemocytes showed no detectable effect on either
tumor burden or tumor cell death (Figure S5E).
Taken together, these data indicate that the innate immune
system can restrict tumor growth in a non-tissue-autonomous
manner through activation of Toll signaling in the fat body.
Hemocyte-Derived Egr Is Necessary to Execute
Toll-Dependent Tumor Cell Death
Finally, given the correlation observed among hemocyte num-
ber, Toll signaling activation in the fat body, and tumor cell death,
we next tested whether hemocyte-derived Egr was required
to execute tumor cell death downstream of Toll activation. We
used cg-gal4 to overexpress Toll in both hemocytes and the
fat body, while simultaneously knocking down egr. Overex-
pression of Toll (dlg40.2; cg > Toll) decreased tumor size and
enhanced tumor cell death (Figures 7A, 7C, and 7D; compare
with Figures S5H and S5I). Remarkably, concomitant overex-
pression of Toll and knockdown of egr (dlg40.2; cg > Toll; egr-
IR) strongly suppressed apoptotic tumor cell death and
increased tumor size (Figures 7B–7D). The knockdown of egr
in the immune tissues, however, did not affect the enhanced
expression of the Toll target drs in the fat body of dlg40.2; cg >
Toll; egr-IR larvae (Figure 7E). These results suggest hemo-
cyte-derived Egr is required downstream of Toll signaling in the
fat body to execute epithelial tumor cell death.
DISCUSSION
In this study, we have investigated the systemic interaction be-
tween the fat body and developing tumors. These data uncover
a non-tissue-autonomous role for Drosophila adipocytes in the
control of tumor growth. This is achieved through a relay of the
Pvf1/Pvr, Spz/Toll, and Eiger signaling pathways (model in
Figure 7F).
Adipocytes Restrain Tumor Burden via Toll Signaling
Research in Drosophila has made seminal contributions to the
understanding of innate immune signaling. The discovery of
the role of Toll-like receptors (TLRs) in innate immunity was
first made in the fruit fly and was rapidly followed by the charac-
terization of their relationship with NFkB signaling (Lemaitre,nd scrib1 (F). The arrow in (E) points to transformed discs, negative for drs-GFP
l Procedures). Animals were raised in control diet (left side of plate) or penicillin/
ead on antibiotic-free LB plates.
d genotypes. Note that scrib1 mutant larvae displayed reporter activation even
otypes. All animals were 11 days old except theWT controls, whichwere 5 days
ing eye disc-only tumors (eyRasV12-scrib1; see Experimental Procedures); ecd1
f tumors displayed low levels of drs (J). Expressing RasV12 or silencing spa¨tzle
levels, respectively (K).
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Figure 5. Eiger Is Upstream of Toll Activation in the Fat Body
(A and B) Micrographs from scrib1 and egr3; scrib1 larvae in the genetic background of the Toll reporter drs-GFP.
(C) qRT-PCR for drs from fat bodies of WT, scrib1, and egr3; scrib1 larvae. Note that drs expression depended on egr.
(D–E) qRT-PCR for drs in dissected fat bodies from dlg larvae expressing GFP, egr-IR, or egr under the control of hml- or cg-gal4. Note that modulating egr
expression levels in hemocytes or the fat body itself did not affect the levels of drs expression in the fat body of dlg mutants.
(F and G) Fluorescent micrographs from whole larvae (F and G) and dissected fat bodies (F’ and G’) from animals expressing dlg-IR alone or in combination with
egr-IR, under the control of sd-gal4 in the genetic background of drs-GFP. Note that whereas the overgrowth of the dlg deficient wing pouch was exacerbated by
egr cosilencing (insets in F and G, DAPI staining in gray), the cosilencing of egr prevented the activation of drs-GFP in the fat body.2004). These studies led to the identification of mammalian TLRs
counterparts and their function in both the innate and adaptive
immune responses (Akira, 2003; Beutler et al., 2003).
Mammalian TLRs are important mediators of cancer-related
inflammation (Karin and Greten, 2005; Maruyama et al., 2011).
Nevertheless, the mechanisms that activate TLR signaling in862 Cell Reports 6, 855–867, March 13, 2014 ª2014 The Authorscancer remain poorly understood. Some evidence suggests
that injured or necrotic cells release molecules not normally
found in the extracellular milieu (e.g., DNA and nuclear proteins)
that act as endogenous ligands for pattern recognition receptors
like TLRs (Kim and Karin, 2011). However, it is difficult to test
genetically the role in vivo of these molecular factors.
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Figure 6. Toll Activation in the Fat Body Remotely Controls Tumor Growth
(A and B) F-Actin stained dlg imaginal disc tumors from the indicated genotypes. Note that silencing spz in the hemocytes of dlgmutant larvae resulted in enlarged
tumors.
(C and D) Quantification of tumor volume and percentage of volume with apoptotic cells (C, t test ****p < 0.0001 and D, ***p = 0.0001). See also Figure S5.
(E–H) Control imaginal disc and imaginal disc tumors from dlg40.2; ppl-gal4 larvae expressingGFP (F),Myd88-IR (G), or Toll (H) and stained for F-actin (green) and
CC3 (red or gray in bottom panels).
(I–J) Quantifications of tumor volume and percentage of tumor volume with apoptotic cells from the indicated genotypes (one-way ANOVA with Bonferroni post
test correction, *p < 0.05; **p < 0.005, ***p < 0.001, ****p < 0.0001).
Note that tumor size is inversely correlated with the levels of Toll signaling in the fat body, whereas the level of tumor cell death correlates directly with Toll
activation.During pathogen infection fly hemocytes produce the Toll
ligand Spa¨tzle to activate Toll signaling in the fat body (Shia
et al., 2009). Remarkably, our results implicate Spz in the tumor
recognition mechanism: spz knockdown in hemocytes resulted
in reduced activation of Toll signaling in the fat body, decreasedtumor cell death, and increased tumor burden. This study sug-
gests the existence of a long-range, intertissue crosstalk be-
tween tumors and adipocytes that requires the hemocytes as
messengers to activate Toll/NFkB signaling in the adipocytes
and to restrain tumor growth.Cell Reports 6, 855–867, March 13, 2014 ª2014 The Authors 863
Figure 7. Toll Activation Requires Eiger to Control Tumor Growth
(A and B) Imaginal disc tumors from dlg40.2; cg-gal4 larvae expressing Toll alone (A) or in combination with egr-IR (B) stained for F-actin (green) and CC3 (red or
gray in bottom panels).
(C and D) Quantification of tumor volume and percentage of volume with apoptotic cells in the indicated genotypes (C, t test ****p < 0.0001 and D, ***p = 0.0003).
Note the increase in tumor volume and the decrease in tumor cell death when egr was silenced together with Toll overexpression using the cg-gal4 driver.
(E) qRT-PCR for drs in dissected fat bodies from dlg larvae expressing either GFP or Toll alone or in combination with egr- under the control of cg-gal4 (one-way
ANOVAwith Bonferroni post test correction, ns: nonsignificant and *p < 0.05). Note that overexpression of Toll resulted in enhanced production of drs, which was
not affected by simultaneously silencing egr.
(F) A model for the two-way communication of epithelial tumors and the fat body. See the text for details.Eiger and Hemocytes in the Immune Modulation of
Tumor Growth
Since Virchow’s first observations, the infiltration of blood cells
has been appreciated as a common feature of solid tumors864 Cell Reports 6, 855–867, March 13, 2014 ª2014 The Authors(Balkwill and Mantovani, 2001). Previous studies on the role
of tumor-associated hemocytes in Drosophila indicate that he-
mocyte number correlates inversely with tumor growth (Pastor-
Pareja et al., 2008) and that hemocytes are recruited from the
circulation into imaginal disc tumors and express egr (Cordero
et al., 2010).
Here we provide additional evidence for a tumor-suppressor
role for the hemocytes in scribble group mutant larvae: (1) func-
tional manipulations of hemocyte number correlated with tumor
cell death, (2) egr expression in hemocytes promoted cell death
in epithelial tumor cells but not in normal cells, and (3) hemocytes
released Venus-labeled Egr on imaginal disc tumors, and this
correlated with apoptosis. This response to tumors requires
Egr to be expressed both by tumor cells and hemocytes. Indeed,
hemocyte-derived Egr was required for tumor cell death. Tumor-
intrinsic expression of Egr might be required for systemic effects
achieved via its target Pvf1, which mediates hemocyte prolifera-
tion. In turn, hemocyte proliferation results in increased produc-
tion of Spz that activates Toll in the fat body.
Recent work demonstrated that tumors and wounds upregu-
late the Insulin-like peptide Dilp8, which prevents Ecdysone pro-
duction to delay pupariation (Colombani et al., 2012; Garelli
et al., 2012). We found that this upregulation was dependent
on egr, and that overexpression of egr in the wing disc pouch
was sufficient to upregulate dilp8 (Figure S3).
Together, these data highlight a central role of Eiger expres-
sion both in tumor cells and hemocytes, for the host response
to tumors.
A Functional Relationship of Egr/TNF and Toll Signaling
In mammals, TNF-a is a well-characterized TLR/NF-kB target,
expressed in inflammatory conditions during infection and
cancer (Balkwill, 2009). In response to tumor burden, our ge-
netic data place Eiger both upstream and downstream of Toll
signaling. In fact, systemic loss of eiger or silencing eiger in
epithelial tumor cells inhibited Toll pathway activation in the fat
body. Conversely, the non-tissue autonomous tumor suppress-
ing effect of Toll via tumor cell death required eiger expression in
the immune tissues. Therefore, Eiger and Toll signaling coop-
erate in a feedforward systemic response to tumor development.
In mammalian systems, inflammatory cytokines such as TNF-a
have been implicated in the systemic effects of high tumor
burden (Balkwill, 2009). Future studies should explore whether
Toll-like receptors are also involved, in particular, in tissues anal-
ogous to the fat body such as the white adipose tissue and liver.
EXPERIMENTAL PROCEDURES
Drosophila Stocks
A list of all fly stocks used and their sources can be found in Table S1.
Fly Husbandry and Genetics
Crosses were performed at 22C in standard oatmeal and molasses medium
(Fernandez-Ayala et al., 2009) and kept in incubators with a controlled 12 hr
light/dark cycle. Crosses were performed in bottles with a controlled number
of females and males and allowed to mate for a maximum of 2 days in order
to control population density. Unless otherwise indicated, tumor-bearing
larvae and ecd1 mutants were dissected 11 days after egg laying (AEL) for tu-
mor, hemolymph, or fat body collection; wild-type-like control larvae were
dissected at the wondering third instar stage. Gal-4 drivers were crossed
into a dlg40.2 background and combined with a UAS-GFP transgene. Larvae
were examined for GFP fluorescence, and the expression pattern of each
Gal-4 driver is shown in Table S2. The expression pattern of sd-gal4 was
examined in a wild-type background and can also be found in Table S2.Immunofluorescence
Tissues were dissected in PBS and fixed 30 min in 4% paraformaldehyde
(Polysciences). After fixation, samples were washed three times in PBS +
0.3% Triton X-100 (PBST) and incubated in primary antibodies and DAPI
(Sigma-Aldrich) overnight at 4C. Samples were washed as previously
described and subjected to secondary antibody staining for 1–2 hr at room
temperature followed by washing and mounting on Vectashield (Vector
Laboratories) using Secured-Seal spacers (Life Technologies) to preserve
the thickness of the tissues. Primary and secondary antibodies were incubated
in PBST + 3% BSA. Primary antibodies used included rabbit anticleaved
caspase 3 (1:200; Cell Signaling Technology), rabbit anti-bgal (1:1,000, Cappel
antibodies) mouse anti-MMP1 (1:10; DSHB), and mouse anti-p1/Nimrod (1:5;
kind gift of I. Ando). Phalloidin 594/647 was used to visualize the cytoskel-
eton (1:200/1:40; Life Technologies). Secondary antibodies used were Alexa
488, 594 (1:200; Life Technologies). Confocal images were captured using a
Zeiss 710 confocal microscope and processed with ImageJ or Adobe
Photoshop CS.
qRT-PCR Analysis
Each total RNA sample was extracted from 10–15 fat bodies or 30 tumors (in
biological triplicates) using the QIAGEN RNeasy kit according to manufac-
turer’s instructions. cDNA synthesis was performed using the High-Capacity
cDNA Reverse Transcription Kit (Applied Biosystems). PerfeCTa SYBR green
(Quanta Biosciences) was used for qRT-PCR followingmanufacturer’s instruc-
tions. A series of 10-fold dilutions of an external standard was used in each run
to produce a standard curve. cDNAwas analyzed in triplicate using an Applied
Biosystems 7500 fast instrument. mRNA levels for the relevant targets were
measured using primers pairs shown in Table S3, and actin5C was used to
normalize target expression levels. Data were extracted and analyzed using
Applied Biosystems 7500 software version 2.0 and Prism GraphPad software.
Data are presented as mean mRNA levels with SEM.
Statistics
Results are presented as scatter plots or bar graphs created using GraphPad
Prism 6. A combination of t test and one-way ANOVA with Bonferroni’s multi-
ple comparison test was used to calculate statistical significance. p values are
included in the relevant figure legends.
Quantification of Tumor Volume and Tumor Cell Death
Tumor volume was quantified from total volume of DAPI on confocal image
series of tumors of all shown genotypes using the Volocity 3D imaging analysis
software (PerkinElmer). For each tumor, 40–50 stacks were taken (2.55 mm/
stack) and were used to render a 3D image; an example is shown in Movie
S1. In most cases, the tumors derived from haltere or leg discs remain associ-
ated with the ones derived from wing discs; these are easily distinguishable in
a dlg40.2 background and were not considered for the quantifications.
Tissues stained for DAPI and cleaved caspase 3 (CC3) were used to quantify
the level of cell death. Volocity 3D software was used to calculate the volume of
the tumor positive for cleaved caspase 3 and was then normalized to total
tumor volume (visualized by DAPI staining) to calculate the percentage tumor
cell death. Twelve to 25 tumors were analyzed for each genotype.
Hemocyte Quantifications
Larvae were washed three times in PBS to remove any food debris. Five larvae
per genotype were then opened and turned inside out using no. 5 forceps
(Dumont) in 500 ml of PBS. The sample was gently pipetted to ensure equal dis-
tribution and avoid clustering, and 10 ml was loaded into each end of a hemo-
cytometer (Bright Line), and the number of hemocytes were counted. The total
number of hemocytes per larva was then calculated. To account for the in-
crease in larval size, the number of hemocytes per larvae was normalized to
the increase in hemolymph weight in tumor-bearing larvae. This ensured that
differences in hemocyte number were not a result of increased hemolymph
but rather an increase in hemocyte density/concentration. To measure larval
weight, at least 15 larvae per genotype were pulled together in a preweighed
Eppendorf tube, and their weight was measured on a high-precision scale
(APX-100, Denver Instrument). These experiments were performed at least
in triplicate for each genotype.Cell Reports 6, 855–867, March 13, 2014 ª2014 The Authors 865
Generation of Eye Disc Tumors
In order to test whether the effects in the fat body of zygotic scrib or dlg mu-
tants was a response to tumors versus a tissue autonomous effect of the dlg
or scribmutation, we used a MARCM system-derived tumor model (Pagliarini
and Xu, 2003) in which clones of scrib1 mutant cells that also overexpress the
RasV12 oncogene are created specifically in the eye-antenna discs using the
tissue specific ey-FLP recombinase (referred to as eyRasV12-scrib1 larvae).
In this case, every tissue, except the eye disc-derived tumors, is heterozygous
for scrib and wild-type-like.
Whole Larva and Adult Wing Imaging
Third instar larvae were washed in dH20, dried, and immobilized on double-
sided tape. Images of were taken using a Leica M205 FA stereomicroscope.
Adult wings were washed in PBS-T and mounted in 50% glycerol in PBS-T,
and images were obtainedwith anOlympusBX51microscope using a 53 lens.
Germ-free-like Conditions
The use of antibiotics was as previously described (Ridley et al., 2013). Briefly,
embryos of drs-GFP; scrib1 larvae were raised in diet containing penicillin and
streptomycin (100 IU/ml and 100 mg/ml, respectively, Gibco). After they devel-
oped as giant larvae, larvae were imaged for GFP signal. To confirm the germ-
free-like conditions, single larvae were homogenized in 30 ml of sterile PBS,
spread on antibiotic-free Luria-Bertani (LB) plates (animals raised in normal
diet were spread in the same plate as internal controls), and incubated at
29C for 48 hr.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, three tables, and one movie
and can be found with this article online at http://dx.doi.org/10.1016/j.
celrep.2014.01.039.
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